145 related articles for article (PubMed ID: 37042197)
1. The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review.
Grandi G; Guariglia G; Facchinetti F
Eur J Contracept Reprod Health Care; 2023 Jun; 28(3):184-191. PubMed ID: 37042197
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
[TBL] [Abstract][Full Text] [Related]
3. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
Thorneycroft lH; Gollnick H; Schellschmidt I
Cutis; 2004 Aug; 74(2):123-30. PubMed ID: 15379365
[TBL] [Abstract][Full Text] [Related]
4. Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives.
Anderson FD
Acta Obstet Gynecol Scand Suppl; 1992; 156():15-21. PubMed ID: 1324552
[TBL] [Abstract][Full Text] [Related]
5. The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris.
Olson WH; Lippman JS; Robisch DM
Int J Fertil Womens Med; 1998; 43(6):286-90. PubMed ID: 9920537
[TBL] [Abstract][Full Text] [Related]
6. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
London RS; Chapdelaine A; Upmalis D; Olson W; Smith J
Acta Obstet Gynecol Scand Suppl; 1992; 156():9-14. PubMed ID: 1324557
[TBL] [Abstract][Full Text] [Related]
7. Combined oral contraceptive pills for treatment of acne.
Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
Cochrane Database Syst Rev; 2012 Jul; (7):CD004425. PubMed ID: 22786490
[TBL] [Abstract][Full Text] [Related]
8. Combined oral contraceptive pills for treatment of acne.
Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
Cochrane Database Syst Rev; 2012 Jun; (6):CD004425. PubMed ID: 22696343
[TBL] [Abstract][Full Text] [Related]
9. A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial.
Jaisamrarn U; Chaovisitsaree S; Angsuwathana S; Nerapusee O
Contraception; 2014 Nov; 90(5):535-41. PubMed ID: 25074072
[TBL] [Abstract][Full Text] [Related]
10. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
[TBL] [Abstract][Full Text] [Related]
11. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
Redmond GP; Olson WH; Lippman JS; Kafrissen ME; Jones TM; Jorizzo JL
Obstet Gynecol; 1997 Apr; 89(4):615-22. PubMed ID: 9083323
[TBL] [Abstract][Full Text] [Related]
12. An open study of Triphasil and Diane 50 in the treatment of acne.
Wishart JM
Australas J Dermatol; 1991; 32(1):51-4. PubMed ID: 1834045
[TBL] [Abstract][Full Text] [Related]
13. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
Mango D; Ricci S; Manna P; Miggiano GA; Serra GB
Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
15. Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgaris. A pilot study.
Sator PG; Schmidt JB; Hönigsmann H
Dermatology; 2003; 206(3):241-8. PubMed ID: 12673082
[TBL] [Abstract][Full Text] [Related]
16. The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne.
Carmina E; Godwin AJ; Stanczyk FZ; Lippman JS; Lobo RA
J Endocrinol Invest; 2002 Oct; 25(9):765-8. PubMed ID: 12398233
[TBL] [Abstract][Full Text] [Related]
17. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
Wiegratz I; Jung-Hoffmann C; Kuhl H
Contraception; 1995 Jun; 51(6):341-6. PubMed ID: 7554973
[TBL] [Abstract][Full Text] [Related]
18. A norgestimate-containing oral contraceptive: review of clinical studies.
Kafrissen ME
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446
[TBL] [Abstract][Full Text] [Related]
19. A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment.
Lucky AW; Koltun W; Thiboutot D; Niknian M; Sampson-Landers C; Korner P; Marr J
Cutis; 2008 Aug; 82(2):143-50. PubMed ID: 18792547
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
Palombo-Kinne E; Schellschmidt I; Schumacher U; Gräser T
Contraception; 2009 Apr; 79(4):282-9. PubMed ID: 19272497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]